삼천당제약(000250) IR 자료
| 제목 | 일시 |
|---|---|
| 삼천당제약, 회사 Main Project 설명 | 2025-04-08T07:10:22.462205+00:00 |
| 삼천당제약, 키움증권 NDR(Non-deal Roadshow) | 2025-02-05T05:02:50.296405+00:00 |
| 삼천당제약, 키움증권 NDR | 2024-04-22T22:10:38.072754+00:00 |
| 삼천당제약, 키움증권 NDR | 2024-04-22T01:10:19.421794+00:00 |
| 삼천당제약-삼천당제약-경구용-인슐린-Human-Pilot-Study-결과 | 2022-07-15T00:42:29+00:00 |
| 삼천당제약-삼천당제약-경구용-인슐린-Human-Pilot-Study-결과 | 2022-07-13T08:42:25+00:00 |
| 삼천당제약-삼천당제약-회사-Main-Project-설명 | 2022-03-18T00:42:31+00:00 |
| 삼천당제약-삼천당제약-회사-Main-Project-설명 | 2022-03-17T07:42:40+00:00 |
| 삼천당제약-삼천당제약-회사-main-project-설명 | 2021-10-27T01:42:34+00:00 |
| 삼천당제약-삼천당제약-회사-main-project-설명 | 2021-10-26T22:42:44+00:00 |
| 삼천당제약-삼천당제약-S-pass-platform-진행-현황-및-향후-계획국내 | 2021-03-25T07:42:05+00:00 |
| 삼천당제약-S패스-기술개요-및-전임상결과-발표국내 | 2020-08-31T15:32:00+00:00 |
| 삼천당제약-삼천당제약-회사소개-및-사업설명국내 | 2020-07-30T00:42:06+00:00 |
| 삼천당제약-삼천당제약-회사의-사업별-진행현황-설명국내 | 2020-02-19T00:10:15+00:00 |
| 삼천당제약, KIS Investors Forum Asia 2019 참가(홍콩/싱가포르) | 2019-02-10T15:00:00+00:00 |